These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30364135)

  • 1. Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review.
    Querin G; Bede P; Marchand-Pauvert V; Pradat PF
    Front Neurol; 2018; 9():844. PubMed ID: 30364135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.
    Querin G; Sorarù G; Pradat PF
    Rev Neurol (Paris); 2017 May; 173(5):326-337. PubMed ID: 28473226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
    Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
    Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion.
    MacLean HE; Warne GL; Zajac JD
    J Neurol Sci; 1996 Feb; 135(2):149-57. PubMed ID: 8867071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations in spinal and bulbar muscular atrophy.
    Francini-Pesenti F; Vitturi N; Tresso S; Sorarù G
    Rev Neurol (Paris); 2020 Dec; 176(10):780-787. PubMed ID: 32631678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
    Pradat PF; Bernard E; Corcia P; Couratier P; Jublanc C; Querin G; Morélot Panzini C; Salachas F; Vial C; Wahbi K; Bede P; Desnuelle C;
    Orphanet J Rare Dis; 2020 Apr; 15(1):90. PubMed ID: 32276665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
    Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Basso M
    J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Gozes I
    J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kennedy's disease: expansion of the CAG trinucleotide].
    Domitrz I; Jedrzejowska M; Lipowska M; Siddique T; Kwieciński H
    Neurol Neurochir Pol; 2001; 35(1 Suppl):107-14. PubMed ID: 11732276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
    Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
    Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
    Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA)].
    Katsuno M; Banno H; Suzuki K; Hashizume A; Adachi H; Tanaka F; Sobue G
    Rinsho Shinkeigaku; 2012; 52(11):1207-9. PubMed ID: 23196565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.
    Rosenbohm A; Hirsch S; Volk AE; Grehl T; Grosskreutz J; Hanisch F; Herrmann A; Kollewe K; Kress W; Meyer T; Petri S; Prudlo J; Wessig C; Müller HP; Dreyhaupt J; Weishaupt J; Kubisch C; Kassubek J; Weydt P; Ludolph AC
    J Neurol; 2018 May; 265(5):1026-1036. PubMed ID: 29464380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system abnormalities in spinal and bulbar muscular atrophy (Kennedy's disease).
    Finsterer J; Scorza FA
    Clin Neurol Neurosurg; 2019 Sep; 184():105426. PubMed ID: 31351215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypospadias as a novel feature in spinal bulbar muscle atrophy.
    Nordenvall AS; Paucar M; Almqvist C; Nordenström A; Frisén L; Nordenskjöld A
    J Neurol; 2016 Apr; 263(4):703-6. PubMed ID: 26872663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
    Finsterer J; Soraru G
    J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.